Drug intelligence / Profile preview

Guben Qushi Decoction

Development stage: Unknown
Lead developer: The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
Administration: Oral

Overview

Guben Qushi Decoction is a traditional Chinese medicine (TCM) formula developed by The Second Affiliated Hospital of Guangzhou University of Chinese Medicine for the treatment of eczema. Specifically formulated for the 'spleen-deficiency dampness-type' TCM syndrome, the decoction aims to strengthen the spleen and eliminate dampness, which are believed to be underlying causes of chronic skin inflammation in this patient population. It is currently being evaluated in clinical trials to assess its safety, clinical efficacy, and preliminary mechanisms of action in adults with eczema.

Other names: Guben Qushi PrescriptionGubenhuashi Decoction

Beyond the preview

Go deeper on Guben Qushi Decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guben Qushi Decoction.

Explore the full profile